Komipharm Raises Government Vaccine Supply Contract Value to KRW 10.41 Billion

Bitget2026/11/04 07:58

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Komipharm International corrected its supply contract value to KRW 10.41 billion, an increase of KRW 332 million, on Nov. 4, 2026.
The amended Public Procurement Service contract covers 14 animal vaccines, up from 13.
The revised value represents 26.16% of 2022 revenue, versus 25.33% previously.
The contract runs from Jan. 16, 2024, through Nov. 5, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Komipharm International Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261104900515), on November 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Komipharm Raises Government Vaccine Supply Contract Value to KRW 10.41 Billion

You may also like

Crypto prices